TOBAM’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-52,311
Closed -$1.74M 471
2022
Q2
$1.74M Sell
52,311
-40,261
-43% -$1.71M 0.11% 107
2022
Q1
$6.68M Sell
92,572
-201,000
-68% -$14.5M 0.34% 80
2021
Q4
$27M Sell
293,572
-24,700
-8% -$2.95M 1.21% 28
2021
Q3
$40.4M Buy
318,272
+42,094
+15% +$6.13M 1.71% 16
2021
Q2
$45.9M Buy
276,178
+52,056
+23% +$8.43M 1.84% 15
2021
Q1
$40.7M Buy
224,122
+852
+0.4% +$198K 1.73% 16
2020
Q4
$44.6M Buy
223,270
+46,857
+27% +$9.53M 1.99% 14
2020
Q3
$38.7M Sell
176,413
-7,366
-4% -$1.56M 1.94% 16
2020
Q2
$35.1M Buy
+183,779
New +$32.2M 2.26% 13

Other funds holding TDOC

TOBAM's TDOC Position: Q3 2022 in Review

TOBAM sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 52,311 shares — an estimated $1.74M sold.

TOBAM first reported a position in TDOC in Q2 2020 and held it in 9 quarters. The position peaked at $45.9M in Q2 2021. 483 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • TOBAM reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • TOBAM sold 52,311 Teladoc Health shares in Q3 2022, an estimated $1.74M.
  • TOBAM first reported a position in Teladoc Health in Q2 2020 and held it in 9 quarters.
  • TOBAM's Teladoc Health position peaked at $45.9M in Q2 2021.
  • 483 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on TOBAM's 13F filing for Q3 2022, filed 2 Nov 2022.